Glucopyranosyl Lipid A Adjuvant Significantly Enhances HIV Specific T and B Cell Responses Elicited by a DNA-MVA-Protein Vaccine Regimen-Reference-Cited by-同舟云学术

Glucopyranosyl Lipid A Adjuvant Significantly Enhances HIV Specific T and B Cell Responses Elicited by a DNA-MVA-Protein Vaccine Regimen

Published:2014-01-23 Issue:1 Volume:9 Page:e84707
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

McKay Paul F.,Cope Alethea V.,Mann Jamie F. S.,Joseph Sarah,Esteban Mariano,Tatoud Roger,Carter Darrick,Reed Steven G.,Weber Jonathan,Shattock Robin J.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference55 articles.

1. A Multi-Vector, Multi-Envelope HIV-1 Vaccine;JL Hurwitz;J Pediatr Pharmacol Ther,2007

2. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand;S Rerks-Ngarm;N Engl J Med,2009

3. Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine;RR Amara;J Virol,2002

4. Effective induction of simian immunodeficiency virus-specific cytotoxic T lymphocytes in macaques by using a multiepitope gene and DNA prime-modified vaccinia virus Ankara boost vaccination regimen;T Hanke;J Virol,1999

5. Heterologous prime-boost vaccination;S Lu;Curr Opin Immunol,2009

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of vaccine type on HIV-1 vaccine elicited antibody durability and B cell gene signature;Scientific Reports;2020-08-03

2. Increasing the Chemical Variety of Small-Molecule-Based TLR4 Modulators: An Overview;Frontiers in Immunology;2020-07-10

3. Recent advances on HIV DNA vaccines development: Stepwise improvements to clinical trials;Journal of Controlled Release;2019-12

4. Effects of cationic adjuvant formulation particle type, fluidity and immunomodulators on delivery and immunogenicity of saRNA;Journal of Controlled Release;2019-06

5. Prime-Boost Immunizations with DNA, Modified Vaccinia Virus Ankara, and Protein-Based Vaccines Elicit Robust HIV-1 Tier 2 Neutralizing Antibodies against the CAP256 Superinfecting Virus;Journal of Virology;2019-04-15